Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Noteable

T.ONC

RE:RE:ONCY Initiates New Pancreatic Cancer GOBLET Cohort

August 30, 2024 - Tumor microenvironment: recent advances in immunotherapies...

September 1, 2024

T.ONC

RE:RE:RE:RE:RE:RE:ONCY's pelareorep activates TiLs (CD8+ Dendritic Cells)

With two Phase 2 clinical trials completed, in metastatic breast cancer...

August 31, 2024

T.ONC

RE:RE:RE:RE:RE:ONCY's pelareorep activates TiLs (CD8+ Dendritic Cells)

Should read: Bracelet-1 -  12 month Phase 2 mOS  data"...

August 30, 2024

T.ONC

RE:RE:RE:RE:ONCY's pelareorep activates TiLs (CD8+ Dendritic Cells)

Overall survival data has  continued to mature  from the BRACELET-1...

August 30, 2024

T.ONC

RE:RE:CD8+ TiLs and T-cell exhaustion

" We found that after every infusion, you have a new immune response...

August 30, 2024

T.ONC

RE:CD8+ TiLs and T-cell exhaustion

August 29, 2024 - Combo immunotherapy produces distinct waves of cancer...

August 30, 2024

T.ONC

RE:RE:TIGIT class of checkpoint inhibitors fails with Keytruda

  Aug 8, 2024 (Reuters) – Merck (MRK.N) said on...

August 30, 2024

T.ONC

RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo

August 21, 2024 - Merck USA (MSD) acquires a single Phase 1 CD3xCD19...

August 30, 2024

T.ONC

RE:RE:RE:How does Accelerated Approval work

Accelerated Approval -> $$$$$$$ 

August 29, 2024

T.ONC

RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

$$$$ 

August 29, 2024

T.ONC

RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs

The IRA’s favorable position is on new large-molecule biologics compared to...

August 29, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:G12D/G12V KRAS mutation in PC & CRC patients respond to Pela

May 2024 -  The Efficacy of Immune Checkpoint Inhibitors in...

August 29, 2024

T.ONC

RE:RE:RE:RE:Merck' anti-PD-1 Keytruda fails as a monotherapy with chemo

ONCY's drug platfrom pelareorep "primes" the immune system and...

August 29, 2024

T.ONC

RE:RE:Merck' anti-PD-1 Keytruda fails as a monotherapy with chemo

May 09, 2024 - "Used as an adjuvant treatment with chemotherapy, ...

August 29, 2024

T.ONC

RE:RE:Merck' anti-PD-1 Keytruda fails as a monotherapy with chemo

August 29, 2024 - Merck's checkpoint inhibitor Keytruda fails as a...

August 29, 2024

T.ONC

RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo

August 27, 2024 - Bispecific T-cell engagers (BiTEs) are designed to link T...

August 27, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

The end to Biotech’s bear market – and early recovery – explained...

August 25, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

After three years of underperformance, the biotech sector is exhibiting...

August 25, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China

The US House Select Committee on the Chinese Communist Party, the driving...

August 25, 2024

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China

Merck is trying to determine the reasons behind the surprise decline of its...

August 25, 2024

Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next

Featured Company

Revive Therapeutics Ltd

Revive Therapeutics Ltd C.RVV

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ... view more »